MX2010004157A - Subgrupos de pacientes novedosos para trombolisis. - Google Patents

Subgrupos de pacientes novedosos para trombolisis.

Info

Publication number
MX2010004157A
MX2010004157A MX2010004157A MX2010004157A MX2010004157A MX 2010004157 A MX2010004157 A MX 2010004157A MX 2010004157 A MX2010004157 A MX 2010004157A MX 2010004157 A MX2010004157 A MX 2010004157A MX 2010004157 A MX2010004157 A MX 2010004157A
Authority
MX
Mexico
Prior art keywords
thrombolysis
patient subgroups
novel patient
patient
novel
Prior art date
Application number
MX2010004157A
Other languages
English (en)
Inventor
Mariola S Hngen
Alice Ebel
Yasir Alaa Shafeek Al Rawi
Original Assignee
Paion Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567844&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010004157(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP07020401A external-priority patent/EP2050462A1/en
Application filed by Paion Deutschland Gmbh filed Critical Paion Deutschland Gmbh
Publication of MX2010004157A publication Critical patent/MX2010004157A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrotherapy Devices (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Un m?todo para tratar un paciente con apoplej?a con trombolisis, donde antes del tratamiento el paciente es diagnosticado en particular por exhibir tejido cerebral en riesgo, oclusi?n de una arteria cerebral y/o "desajuste de volumen" absoluto.
MX2010004157A 2007-10-18 2008-10-20 Subgrupos de pacientes novedosos para trombolisis. MX2010004157A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP07020401A EP2050462A1 (en) 2007-10-18 2007-10-18 Improved treatment of stroke patients
EP07022867 2007-11-26
EP08017954 2008-10-15
PCT/EP2008/008871 WO2009049914A2 (en) 2007-10-18 2008-10-20 Novel patient subgroups for thrombolysis

Publications (1)

Publication Number Publication Date
MX2010004157A true MX2010004157A (es) 2010-04-30

Family

ID=40567844

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004157A MX2010004157A (es) 2007-10-18 2008-10-20 Subgrupos de pacientes novedosos para trombolisis.

Country Status (29)

Country Link
US (2) US20100272704A1 (es)
EP (1) EP2211898B1 (es)
JP (2) JP5509085B2 (es)
KR (1) KR20100089077A (es)
CN (1) CN101903039B (es)
AR (1) AR068914A1 (es)
AU (1) AU2008314048B2 (es)
BR (1) BRPI0817785A2 (es)
CA (1) CA2702378A1 (es)
CL (1) CL2009000752A1 (es)
CY (1) CY1118417T1 (es)
DK (1) DK2211898T3 (es)
EA (1) EA020776B1 (es)
ES (1) ES2611155T3 (es)
HK (1) HK1151233A1 (es)
HR (1) HRP20170001T1 (es)
HU (1) HUE032867T2 (es)
IL (1) IL205175A0 (es)
LT (1) LT2211898T (es)
MX (1) MX2010004157A (es)
MY (1) MY159200A (es)
NZ (1) NZ584640A (es)
PL (1) PL2211898T3 (es)
PT (1) PT2211898T (es)
RS (1) RS55590B1 (es)
SI (1) SI2211898T1 (es)
TW (1) TWI482628B (es)
WO (1) WO2009049914A2 (es)
ZA (1) ZA201002548B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US5244806A (en) * 1985-08-26 1993-09-14 Eli Lilly And Company DNA encoding novel tissue plasminogen activator derivatives having kringles 1 and 2 deleted, vectors and host cells
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of a tissue plasminogen activator containing the Pringle 2 and protease regions only, DNA encoding it, processes for its preparation, and pharmaceutical preparations containing it
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5676947A (en) * 1989-02-07 1997-10-14 Boehringer Manneheim Gmbh Method for treating thromboembolic conditions using thrombolytically active proteins
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
US6008019A (en) * 1989-02-13 1999-12-28 Schering Aktiengesellschaft Plasminogen activator from saliva of the vampire bat
US5891664A (en) * 1989-04-07 1999-04-06 Cancerforskningsfondet Af 1989 Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)
US5326700A (en) * 1990-11-06 1994-07-05 Eli Lilly And Company DNA sequences encoding t-PA derivatives with cleavable sites
ATE132373T1 (de) * 1991-04-16 1996-01-15 Boehringer Mannheim Gmbh Pharmazeutische verpackungseinheit enthaltend plasminogenaktivatoren zur mehrfachbolusgabe
US5595736A (en) * 1991-04-22 1997-01-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders
ATE156519T1 (de) * 1992-12-04 1997-08-15 Schering Ag Thrombininhibitor aus speichel von protostomiern
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
GB9412131D0 (en) * 1994-06-17 1994-08-10 British Bio Technology Thrombolytic composition
US5827832A (en) * 1995-03-06 1998-10-27 Interneuron Pharmaceuticals, Inc. Method of protecting brain tissue from cerebral infarction subsequent to ischemia
US5786187A (en) * 1995-09-21 1998-07-28 The Research Foundation Of State University Of New York Method for reducing neuronal degeneration associated with seizure
US5945432A (en) * 1995-12-22 1999-08-31 The University Of Vermont And State Agricultural College Thrombolytic agents and thienopyridine derivatives in acute stroke
US20020081294A1 (en) * 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
US5731186A (en) * 1996-02-05 1998-03-24 Schering Aktiengesellschaft Method for the production of rDSPA α1
US6354999B1 (en) * 2000-01-14 2002-03-12 Florence Medical Ltd. System and method for detecting, localizing, and characterizing occlusions and aneurysms in a vessel
GB0025473D0 (en) * 2000-10-17 2000-11-29 Pfizer Ltd Pharmaceutical combinations
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
US20060135425A1 (en) * 2003-05-02 2006-06-22 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
US20080057050A1 (en) * 2003-05-02 2008-03-06 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
MXPA05011762A (es) * 2003-05-05 2006-03-30 Paion Deutschland Gmbh Antagonistas de receptor de glutamato como neuroprotectores.
WO2005018564A2 (en) * 2003-08-22 2005-03-03 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage
BRPI0615266A2 (pt) * 2005-08-25 2011-05-17 Biogen Idec Inc polipeptìdeos nogo receptor e fragmentos de polipeptìdeo e usos destes

Also Published As

Publication number Publication date
US20100272704A1 (en) 2010-10-28
CN101903039A (zh) 2010-12-01
JP5509085B2 (ja) 2014-06-04
EP2211898B1 (en) 2016-12-07
JP2011500617A (ja) 2011-01-06
PT2211898T (pt) 2017-01-31
ES2611155T3 (es) 2017-05-05
KR20100089077A (ko) 2010-08-11
AR068914A1 (es) 2009-12-16
WO2009049914A2 (en) 2009-04-23
EA201070485A1 (ru) 2010-10-29
SI2211898T1 (sl) 2017-02-28
AU2008314048B2 (en) 2013-07-25
IL205175A0 (en) 2010-11-30
AU2008314048A1 (en) 2009-04-23
CY1118417T1 (el) 2017-06-28
HK1151233A1 (en) 2012-01-27
DK2211898T3 (en) 2017-01-30
PL2211898T3 (pl) 2017-03-31
TWI482628B (zh) 2015-05-01
TW200927164A (en) 2009-07-01
HRP20170001T1 (hr) 2017-02-24
EP2211898A2 (en) 2010-08-04
HUE032867T2 (en) 2017-11-28
LT2211898T (lt) 2017-01-25
JP2014065739A (ja) 2014-04-17
CN101903039B (zh) 2014-04-02
MY159200A (en) 2016-12-30
RS55590B1 (sr) 2017-06-30
CL2009000752A1 (es) 2009-12-04
BRPI0817785A2 (pt) 2015-03-24
ZA201002548B (en) 2011-06-29
CA2702378A1 (en) 2009-04-23
NZ584640A (en) 2012-10-26
WO2009049914A3 (en) 2009-08-06
US20140314736A1 (en) 2014-10-23
EA020776B1 (ru) 2015-01-30

Similar Documents

Publication Publication Date Title
MX2010003940A (es) Dispositivo para el tratamiento de aneurisma.
DE602004007555D1 (de) Implantat zur okklusion eines körperkanals
GB0518219D0 (en) Improvements in or relating to cryogenic therapeutic treatments
MX2011007578A (es) Metodos para diagnosticar y tratar la disfagia.
WO2010065435A3 (en) System and method for mechanical closure of wounds
WO2005027993A3 (en) Vascular access preservation in hemodialysis patients
WO2006122327A3 (en) Milk fat globule epidermal growth factor-factor viii and sepsis
WO2014016816A3 (pt) Malha polímerica com permeabilidade seletiva, para a regeneraçâo/reparação de tecidos
HK1078776A1 (en) Vitreoretinal tamponades based on fluorosilicone fluids
EP2789338A3 (en) Condensed pyridine derivate and use thereof
HK1098086A1 (en) Use of dapsone as a neuroprotector in preparing medicament for brain stroke
UA100994C2 (ru) Применение десмотеплазы для лечения инсульта
EP2716285A3 (en) New method for identifying compounds useful for treating and/or preventing diseases associated with bone loss
MX2010004157A (es) Subgrupos de pacientes novedosos para trombolisis.
MX352500B (es) Aplicación de esfuerzo cortante para el tratamiento de enfermedades.
WO2006007710A3 (en) Acute inflammatory condition treatment
TW200640484A (en) Treatment of brain tissue damage
UA34714U (en) Method for autodermoplasty
UA40977U (ru) Способ определения показаний к хирургическому лечению рецидивного холедохолитиаза
Hong et al. Obturator internus muscle injection therapy in a patient with buttock pain and radiating pain to the lower extremities
UA37078U (ru) Способ профилактики рефлюкс-холангита при хирургическом лечении больных с механической желтухой
UA29556U (ru) Способ лечения больных острыми вирусными менингитами
UA36369U (ru) Способ лечения артериальной гипертензии на санаторно-курортном этапе
UA40976U (ru) Способ диагностики рецидивного холедохолитиаза
UA29851U (ru) Способ лечения нарушений ритма сердца у больных с артериовенозными мальформациями головного мозга в раннем послеоперационном периоде

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: H. LUNDBECK A/S

FG Grant or registration